Daniel Tarsy

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. doi request reprint Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs
    Daniel Tarsy
    Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Handb Clin Neurol 100:601-16. 2011
  2. doi request reprint Treatment of Parkinson disease: a 64-year-old man with motor complications of advanced Parkinson disease
    Daniel Tarsy
    Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    JAMA 307:2305-14. 2012
  3. ncbi request reprint Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy
    Daniel Tarsy
    Department of Neurology, Division of Neurosurgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Neurology 61:247-9. 2003
  4. ncbi request reprint Progression of Parkinson's disease following thalamic deep brain stimulation for tremor
    Daniel Tarsy
    Department of Neurology, Movement Disorders Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Stereotact Funct Neurosurg 83:222-7. 2005
  5. ncbi request reprint Unusual position-sensitive jaw tremor responsive to botulinum toxin
    Daniel Tarsy
    Parkinson s Disease and Movement Disorders Center, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Mov Disord 21:277-8. 2006
  6. ncbi request reprint Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics?
    Daniel Tarsy
    Department of Neurology, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    Mov Disord 21:589-98. 2006
  7. doi request reprint Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease
    Steven R Schwid
    Department of Neurology, University of Rochester, Rochester, New York, USA
    Mov Disord 25:1801-8. 2010
  8. pmc The c.-237_236GA>TT THAP1 sequence variant does not increase risk for primary dystonia
    Jianfeng Xiao
    Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA
    Mov Disord 26:549-52. 2011
  9. doi request reprint Sustained dyskinesias following elective cessation and reactivation of chronic subthalamic nucleus deep brain stimulation for a surgical procedure
    Ludy C Shih
    Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Neuromodulation 14:512-4; discussion 514. 2011
  10. ncbi request reprint End of day dyskinesia in advanced Parkinson's disease can be eliminated by bilateral subthalamic nucleus or globus pallidus deep brain stimulation
    Diana Apetauerova
    Department of Neurology, Lahey Clinic Medical Center, Burlington, Massachusetts, USA
    Mov Disord 21:1277-9. 2006

Detail Information

Publications31

  1. doi request reprint Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs
    Daniel Tarsy
    Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Handb Clin Neurol 100:601-16. 2011
    ....
  2. doi request reprint Treatment of Parkinson disease: a 64-year-old man with motor complications of advanced Parkinson disease
    Daniel Tarsy
    Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    JAMA 307:2305-14. 2012
    ..The case of Mr L, a man with an 11-year history of Parkinson disease, illustrates these emerging motor complications and the manner in which they may be managed both medically and surgically...
  3. ncbi request reprint Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy
    Daniel Tarsy
    Department of Neurology, Division of Neurosurgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Neurology 61:247-9. 2003
    ..Pulse generators were turned off. Clinical features and brain MRI in this case were indicative of multiple system atrophy (MSA). STN DBS is not recommended for patients with MSA...
  4. ncbi request reprint Progression of Parkinson's disease following thalamic deep brain stimulation for tremor
    Daniel Tarsy
    Department of Neurology, Movement Disorders Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Stereotact Funct Neurosurg 83:222-7. 2005
    ..UPDRS III motor scores were unchanged. However, global assessment of PD progression and increased mean L-dopa dose and L-dopa equivalent daily dose at the time of last follow-up visit indicated that a progression of PD had occurred...
  5. ncbi request reprint Unusual position-sensitive jaw tremor responsive to botulinum toxin
    Daniel Tarsy
    Parkinson s Disease and Movement Disorders Center, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Mov Disord 21:277-8. 2006
    ..Electromyography demonstrated a rhythmic 5 Hz alternating tremor involving masseter and digastric muscles with normal reciprocal inhibition. The tremor was markedly reduced with botulinum toxin injections...
  6. ncbi request reprint Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics?
    Daniel Tarsy
    Department of Neurology, Harvard Medical School, and Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    Mov Disord 21:589-98. 2006
    ..Long-term use of APDs should continue to be based on research-supported indications, with regular specific examination for emerging TD...
  7. doi request reprint Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease
    Steven R Schwid
    Department of Neurology, University of Rochester, Rochester, New York, USA
    Mov Disord 25:1801-8. 2010
    ..Melanoma occurrence in our PD patients was greater than predicted compared with the general population and was unrelated to dopaminergic therapy. Clinical surveillance of PD patients for melanoma may be warranted...
  8. pmc The c.-237_236GA>TT THAP1 sequence variant does not increase risk for primary dystonia
    Jianfeng Xiao
    Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA
    Mov Disord 26:549-52. 2011
    ..Sequence variants in coding and noncoding regions of THAP1 have been associated with primary dystonia...
  9. doi request reprint Sustained dyskinesias following elective cessation and reactivation of chronic subthalamic nucleus deep brain stimulation for a surgical procedure
    Ludy C Shih
    Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Neuromodulation 14:512-4; discussion 514. 2011
    ..We report a patient with previously well-controlled dyskinesias who had severe and prolonged dyskinesias following reactivation of deep brain stimulation (DBS) following an orthopedic procedure...
  10. ncbi request reprint End of day dyskinesia in advanced Parkinson's disease can be eliminated by bilateral subthalamic nucleus or globus pallidus deep brain stimulation
    Diana Apetauerova
    Department of Neurology, Lahey Clinic Medical Center, Burlington, Massachusetts, USA
    Mov Disord 21:1277-9. 2006
    ..Globus pallidus (GPi) DBS in 1 case and subthalamic (STN) DBS in the second case produced full resolution of end of day dyskinesia...
  11. doi request reprint Loss of benefit in VIM thalamic deep brain stimulation (DBS) for essential tremor (ET): how prevalent is it?
    Ludy C Shih
    Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Parkinsonism Relat Disord 19:676-9. 2013
    ..In addition, this data suggests that a disease-based explanation rather than technical factors are more likely to explain the decline in benefit...
  12. doi request reprint Singing in groups for Parkinson's disease (SING-PD): a pilot study of group singing therapy for PD-related voice/speech disorders
    Ludy C Shih
    Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
    Parkinsonism Relat Disord 18:548-52. 2012
    ..This study suggests that a group singing therapy intervention at this intensity and frequency does not result in significant improvement in objective and subject-rated measures of voice and speech impairment...
  13. doi request reprint Survey of U.S. neurologists' attitudes towards deep brain stimulation for Parkinson's disease
    Ludy C Shih
    Department of Neurology, National Parkinson Foundation Center of Excellence, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
    Neuromodulation 14:208-13; discussion 213. 2011
    ..Our aim was to assess attitudes of U.S. neurologists towards the role of DBS in management of advanced PD...
  14. ncbi request reprint A heteroplasmic mitochondrial complex I gene mutation in adult-onset dystonia
    David K Simon
    Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Institutes of Medicine, Boston, MA 02115, USA
    Neurogenetics 4:199-205. 2003
    ..01). This difference remains significant even after excluding the index patient (P=0.04). These data suggest that, among haplogroup H subjects, the presence of the A3796G mutation increases the risk of developing adult-onset dystonia...
  15. doi request reprint A web-based system for home monitoring of patients with Parkinson's disease using wearable sensors
    Bor Rong Chen
    Harvard School of Engineering and Applied Sciences, Cambridge, MA 02138, USA
    IEEE Trans Biomed Eng 58:831-6. 2011
    ..These results indicate that the proposed platform is suitable to monitor patients with PD to facilitate the titration of medications in the late stages of the disease...
  16. ncbi request reprint Long-term evaluation of deep brain stimulation of the thalamus
    Rajesh Pahwa
    Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
    J Neurosurg 104:506-12. 2006
    ..The aim of this study was to evaluate the long-term safety and efficacy of DBS of the ventralis intermedius nucleus (VIM) of the thalamus for PD and ET...
  17. doi request reprint A longitudinal program for biomarker development in Parkinson's disease: a feasibility study
    Bernard Ravina
    Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    Mov Disord 24:2081-90. 2009
    ..The PostCEPT cohort and associated studies strongly support the feasibility of the LABS-PD approach of retaining and repurposing clinical trial cohorts to collect longitudinal clinical and biomarker data...
  18. ncbi request reprint Tardive tremor due to metoclopramide
    Daniel Tarsy
    Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    Mov Disord 17:620-1. 2002
    ..We describe a patient with persistent tardive tremor that was associated with tardive dyskinesia, who closely resembles previously reported cases...
  19. pmc High-throughput mutational analysis of TOR1A in primary dystonia
    Jianfeng Xiao
    Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA
    BMC Med Genet 10:24. 2009
    ..The aim of this study was to identify TOR1A Exon 5 mutations in a large cohort of subjects with mainly non-generalized primary dystonia...
  20. doi request reprint Home monitoring of patients with Parkinson's disease via wearable technology and a web-based application
    Shyamal Patel
    Department of Physical Medicine and Rehabilitation, Harvard Medical School, Spaulding Rehabilitation Hospital, Boston, MA 02114, USA
    Conf Proc IEEE Eng Med Biol Soc 2010:4411-4. 2010
    ..The work herein presented shows that wearable sensors combined with a web-based application provide reliable quantitative information that can be used for clinical decision making...
  21. pmc Serum urate as a predictor of clinical and radiographic progression in Parkinson disease
    Michael A Schwarzschild
    MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Boston, USA
    Arch Neurol 65:716-23. 2008
    ..To determine whether concentration of serum urate, a purine metabolite and potent antioxidant that has been linked to a reduced risk of Parkinson disease (PD), predicts prognosis in PD...
  22. ncbi request reprint Effects of newer antipsychotics on extrapyramidal function
    Daniel Tarsy
    Department of Neurology, Harvard Medical School and the Beth Israel Deaconess Medical Center, Boston, Massachusetts 02115, USA
    CNS Drugs 16:23-45. 2002
    ..In summary, with the exception of clozapine, and perhaps quetiapine, atypical antipsychotics have brought only relative avoidance of EPS, strongly encouraging continued searches for novel antipsychotic agents...
  23. ncbi request reprint Deep brain stimulation for the treatment of atypical parkinsonism
    Ludy C Shih
    Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Mov Disord 22:2149-55. 2007
    ..We review in detail the experience of DBS surgery in patients with several forms of AP including multiple system atrophy. On the basis of the limited available data reviewed here, DBS for patients with AP is not recommended...
  24. ncbi request reprint Dystonia
    Daniel Tarsy
    Department of Neurology, Parkinson s Disease and Movement Disorders Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, USA
    N Engl J Med 355:818-29. 2006
  25. ncbi request reprint Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients
    Matthew B Stern
    University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Mov Disord 19:916-23. 2004
    ..05, Fisher's exact test). The frequency and types of adverse events reported by rasagiline-treated and placebo-treated patients were similar. These results suggest that rasagiline monotherapy is well tolerated and efficacious in early PD...
  26. ncbi request reprint Diabetic gastroparesis
    Daniel Tarsy
    N Engl J Med 357:419; author reply 419-20. 2007
  27. ncbi request reprint Treatment of dystonia
    Roongroj Bhidayasiri
    Chulalongkorn University Hospital, Chulalongkorn Comprehensive Movement Disorders Center, Division of Neurology, 1873 Rama 4 Road Bangkok 10330, Thailand
    Expert Rev Neurother 6:863-86. 2006
    ..Therefore, more research is needed to better understand the underlying cause and pathophysiology of dystonia and to explore newer medications and surgical techniques for its treatment...
  28. doi request reprint Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials
    Gregory S Connor
    Neurological Center of Oklahoma, Inc, Tulsa, OK 74136, USA
    Clin Neuropharmacol 31:97-103. 2008
    ..To evaluate topiramate in adults with essential tremor...
  29. ncbi request reprint Nonlinear sensory cortex response to simultaneous tactile stimuli in writer's cramp
    Terence D Sanger
    Department of Child Neurology, Stanford University Medical Center, Stanford, California USA
    Mov Disord 17:105-11. 2002
    ..Results indicate a nonlinear interaction between the sensory cortical response to individual finger stimulation in writer's cramp. This altered interaction may contribute to the motor abnormalities...
  30. ncbi request reprint Deep-brain stimulation for dystonia: new twists in assessment
    Daniel Tarsy
    Lancet Neurol 6:201-2. 2007